Cargando…
Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options
Coronavirus disease-2019 (COVID-19) pandemic started from Wuhan, China has infected more than 6.7 million individuals and killed more than 390,000 individuals globally. Due to the higher transmissibility and infectiousness, asymptomatic infection, and lack of effective treatment options and vaccine,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381894/ https://www.ncbi.nlm.nih.gov/pubmed/32741731 http://dx.doi.org/10.1016/j.jiph.2020.07.010 |
_version_ | 1783563142832324608 |
---|---|
author | Khan, Suliman Siddique, Rabeea Bai, Qian Shabana Liu, Yang Xue, Mengzhou Nabi, Ghulam Liu, Jianbo |
author_facet | Khan, Suliman Siddique, Rabeea Bai, Qian Shabana Liu, Yang Xue, Mengzhou Nabi, Ghulam Liu, Jianbo |
author_sort | Khan, Suliman |
collection | PubMed |
description | Coronavirus disease-2019 (COVID-19) pandemic started from Wuhan, China has infected more than 6.7 million individuals and killed more than 390,000 individuals globally. Due to the higher transmissibility and infectiousness, asymptomatic infection, and lack of effective treatment options and vaccine, fatalities and morbidities are increasing day by day globally. Despite physical health consequences, COVID-19 pandemic has created stress and anxiety, as result there is an increased risk of mental illnesses both in the infected and normal individuals. To eradicate these risks, it is necessary to determine the COVID-19 zoonotic source of transmission to humans and clinical manifestations in infected individuals. Although, identification or development of the highly effective therapeutic agents is necessary, however, development of protective strategies against the COVID-19 by enhancing immune responses will be an asset in the current scenarios of the COVID-19 pandemic. In this paper, we discuss the transmission, health consequences, and potential management (therapeutic and preventive) options for COVID-19 disease. |
format | Online Article Text |
id | pubmed-7381894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73818942020-07-28 Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options Khan, Suliman Siddique, Rabeea Bai, Qian Shabana Liu, Yang Xue, Mengzhou Nabi, Ghulam Liu, Jianbo J Infect Public Health Review Article Coronavirus disease-2019 (COVID-19) pandemic started from Wuhan, China has infected more than 6.7 million individuals and killed more than 390,000 individuals globally. Due to the higher transmissibility and infectiousness, asymptomatic infection, and lack of effective treatment options and vaccine, fatalities and morbidities are increasing day by day globally. Despite physical health consequences, COVID-19 pandemic has created stress and anxiety, as result there is an increased risk of mental illnesses both in the infected and normal individuals. To eradicate these risks, it is necessary to determine the COVID-19 zoonotic source of transmission to humans and clinical manifestations in infected individuals. Although, identification or development of the highly effective therapeutic agents is necessary, however, development of protective strategies against the COVID-19 by enhancing immune responses will be an asset in the current scenarios of the COVID-19 pandemic. In this paper, we discuss the transmission, health consequences, and potential management (therapeutic and preventive) options for COVID-19 disease. The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2020-12 2020-07-25 /pmc/articles/PMC7381894/ /pubmed/32741731 http://dx.doi.org/10.1016/j.jiph.2020.07.010 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Article Khan, Suliman Siddique, Rabeea Bai, Qian Shabana Liu, Yang Xue, Mengzhou Nabi, Ghulam Liu, Jianbo Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options |
title | Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options |
title_full | Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options |
title_fullStr | Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options |
title_full_unstemmed | Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options |
title_short | Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options |
title_sort | coronaviruses disease 2019 (covid-19): causative agent, mental health concerns, and potential management options |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381894/ https://www.ncbi.nlm.nih.gov/pubmed/32741731 http://dx.doi.org/10.1016/j.jiph.2020.07.010 |
work_keys_str_mv | AT khansuliman coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions AT siddiquerabeea coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions AT baiqian coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions AT shabana coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions AT liuyang coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions AT xuemengzhou coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions AT nabighulam coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions AT liujianbo coronavirusesdisease2019covid19causativeagentmentalhealthconcernsandpotentialmanagementoptions |